Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Apr 13;13:786767. doi: 10.3389/fphar.2022.786767

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2022 Tye, de Vries, Mann, Schechter, Mosenzon, Denig and Heerspink.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

Predicted risk change for the composite kidney (doubling of serum creatinine or ESKD) and the composite cardiovascular (non-fatal myocardial infarction, non-fatal stroke, or cardiovascular death) outcome in the total population based on single risk marker as well as the PRE score, using risk markers changes from baseline to 6-months or first available follow up (N = 9,340). Bars indicate estimates of the mean change in relative risk for specific outcomes with 95% confidence intervals, as compared to placebo. HbA1c, glycated hemoglobin; BP, blood pressure; UACR, urinary-albumin-creatinine-ratio; HDL, high-density-lipoprotein; LDL, low-density-lipoprotein; PRE score, Parameter Response Efficacy score; ESKD, end stage kidney disease.